Generate Biomedicines (GENB) Stock Price & Financial Analysis
Generate Biomedicines Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Generate Biomedicines
What is the current stock price for GENB?
As of the latest trading session, GENB stock trades at $15.53. The 52-week range is $11.00–$22.67, with a day range of $15.20–$16.23.
What is the P/E ratio for GENB?
The P/E ratio (Price-to-Earnings) for GENB is shown in the Key Statistics section. This valuation metric helps compare Generate Biomedicines, Inc. to industry peers.
Does GENB pay dividends?
Generate Biomedicines does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for GENB?
Based on 5 analysts, the consensus for GENB is Buy.
What is the market cap of GENB?
Generate Biomedicines's market capitalization is $1.99B, classifying it as a small-cap company. Generate Biomedicines operates in the Healthcare sector within the Biotechnology industry.